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ABSTRACT 
Objective: The aim of this study is to describe pregnancy outcomes among women with juvenile 
idiopathic arthritis (JIA). 
Methods: Women who gave birth in New South Wales (NSW), Australia, were linked to 
hospital discharge records from 2000-2010.  Women with an ICD-10-AM code of M08 or M09 
in the hospital records were considered to have JIA.  Logistic regression was used to calculate 
odds ratios for pregnancy outcomes and the lack of independence in study outcomes for multiple 
pregnancies in the same woman was taken into account using generalised estimating equations. 
Results: During the study period, 601,659 women had 941,496 births.  Of these births, 78 births 
could be attributed to 50 women with JIA.  Of the 78 JIA pregnancies, 53 (68%) were delivered 
by either CS (n=40, 51%) or instrumental delivery (n=13, 17%); and compared to the other 
women, those with JIA had significantly higher rates of preeclampsia, postpartum haemorrhage 
and severe maternal morbidity.  Compared to other infants, those with mothers with JIA were 
more likely to be born premature but were not at increased risk of being small for gestational 
age, requiring neonatal intensive care, low Apgar score at 5 minutes or severe neonatal 
morbidity. 
Conclusions: Infants of women with JIA did not have an increased risk of adverse neonatal 
outcomes.  Intensive obstetric care might be required during pregnancy for women with JIA 
given the increased risk of maternal morbidity.. 
 
3 
 
 
Key messages: 
Women with JIA are at increased risk of maternal complications. 
Risk of adverse neonatal outcomes is not increased except preterm birth. 
Medical advice and intensive obstetric care should be provided.   
 
INTRODUCTION 
Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disease of the joints and extra-
articular tissue, and can lead to long-term damage of the affected areas. About 10% to 20% of 
adults with juvenile-onset arthritis have moderate to severe functional limitations [1].  Many 
adults with a history of JIA also have a poor self image of their body, exhibit anxiety and 
depression, and report reduced social activity [1,2].  The overall prevalence of juvenile-onset 
arthritis in women of childbearing age is estimated to be about 1 to 2 per 1,000 women [1,3].  
Physical impairments and the associated psychological aspects of JIA will have impacts on all 
aspects of life including women’s reproduction.  Compared to their healthy counterparts, women 
with a history of JIA have similar desire to have children but are more reluctant to become 
pregnant and the cited reasons include functional impairment, fear of transmitting JIA to their 
offspring and physician’s advice [4,5].  
 
Several studies have investigated the impacts of JIA on women’s reproduction and the results are 
mainly based on self-reported information (questionnaire) with contradictory findings [2,5-7].  In 
a recent study of 75 Norwegian women with JIA, only 43% (n=32) had a history of pregnancy 
compared to the rate of 59% in the general population, a 16% reduction in pregnancy rate [7].  
4 
 
Some studies also reported an increased rate of miscarriages or abortions in women with JIA [5].  
In contrast, other studies observed similar rates of live birth and miscarriages in women with JIA 
[6].  With the exception of a reported increase in risk of caesarean section (CS) [4], there is 
almost no information on neonatal and maternal outcomes of pregnancies among women with 
JIA.  
 
This study describes pregnancy outcomes among women with a history of JIA and compares 
their outcomes with the general population using population health data.  Understanding the 
consequences should provide important insights into target areas for health care providers and 
for counselling women with JIA who are prepared to or have already become pregnant about 
what to expect for their birth. 
 
METHODS 
Data sources and study population  
Two population health datasets were used: the New South Wales (NSW) Perinatal Data 
Collection (‘birth data’) and the NSW Admitted Patient Data Collection (‘hospital data’).  The 
birth data include all live births or stillbirths of at least 20 weeks gestation or at least 400 grams 
birth weight in NSW.  Information collected in the birth data includes demographics, number of 
previous births and maternal health, pregnancy, labour, delivery, and perinatal outcomes.  The 
hospital data covers every inpatient admission in NSW, and includes demographic and episode-
related data.  Data from the medical records are coded according to the tenth revision of the 
International Classification of Diseases Australian Modification (ICD-10-AM) and the affiliated 
Australian Classification of Health Interventions [8].  Record linkage of birth data and hospital 
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data (both mother and baby) by the Centre for Health Record Linkage [9] was approved by the 
NSW Population and Health Services Research Ethics Committee.  Only de-identified data were 
made available to researchers. 
 
Women in the birth dataset were linked to their medical records in the hospital data from July 1, 
2000 to December 31, 2010.  Women with an ICD-10-AM code of M08 or M09 in any hospital 
record in the linked dataset were considered as having had juvenile-onset arthritis and were 
compared to other women giving birth during the study period.  A diagnosis could be recorded in 
antenatal, birth and postpartum hospital records as well as records prior to pregnancy for women 
who gave birth during the study period.  Up to 20 diagnoses and 20 procedures in each record 
were used for disease identification in this study. 
 
Ascertainment of risk factors and study outcomes 
Variables ascertained from birth data and/or hospital data included maternal age, maternal 
hypertension (gestational, preeclampsia or chronic), maternal diabetes (gestational or pre-
gestational), smoking during pregnancy, socio-economic status based on residential postcode 
(Index of Relative Socio-economic Disadvantage [10]), inter-pregnancy interval (interval 
between first and second births minus gestational age of the second birth), number of births, any 
abortion or miscarriage (including those before 20 weeks gestation), preterm birth (<37 weeks 
gestation), infants small for gestational age (birth weight<10th percentile for age and sex [11]), 
Apgar score at 5 minutes (<7), admission to neonatal intensive care unit (NICU >4 hours), severe 
neonatal morbidity (a composite indicator for measuring severe adverse neonatal outcomes [12]), 
CS, labour induction, episiotomy, instrumental delivery, antepartum haemorrhage (including 
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placental abruption), preeclampsia, postpartum haemorrhage, severe maternal morbidity (a 
composite indicator for measuring major maternal morbidity [13]), severe perineal trauma (3rd-
4th degree tear) and length of hospital stay for mother.  
 
Data analysis 
Differences between women with and without JIA in age at first birth, abortion rate, length of 
hospital stay, the first and second pregnancy interval, number of births, proportion of women 
with more than one birth etc were compared using the chi-square test, ANOVA test or Wilcoxon 
rank-sum test where appropriate.  Logistic regression analysis was used to calculate odds ratios 
(OR) for each pregnancy outcome for women with JIA compared with the rest of the birthing 
population; the lack of independence in study outcomes for multiple pregnancies in the same 
woman was taken into account using generalised estimating equations (GEE).  The analyses 
were performed with and without adjusting for known determinants of pregnancy outcomes. 
 
RESULTS 
During the study period, 601,659 women had 941,496 births.  Of these, 78 births could be 
attributed to 50 women who had a diagnosis code of juvenile arthritis in the hospital data.  Based 
on the last birth record, the average number of births was 1.8 for women with JIA and 2.2 for the 
wider birthing population (Table 1).  The frequency distribution of pregnancies for the women 
with and without JIA is shown in Figure 1.  There were 19 women with JIA who had both first 
and second birth records in this dataset.  
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Median age at first birth was similar for women with JIA and the rest of the birthing population 
(P=0.07)(Table 1).  For women with JIA, maternal age for any birth ranged from 16.4 to 42.3 
years.  Of these 50 women, 6 (12%) had an abortion or miscarriage during the study period; this 
rate was not different from the 16% observed in the wider birthing population (P=0.48).  With 
respect to fertility after the first birth, a significantly smaller proportion of women with JIA 
(48%) had more than one birth than in the wider birthing population (68%, P=0.003).  However, 
among those who did have more than one birth, there was no difference in first to second 
pregnancy interval between the two groups (Table 1, P=0.67 for median).  
Of the 78 JIA pregnancies, 53 (68%) were delivered by either CS (n=40, 51%) or instrumental 
delivery (n=13, 17%).  Among the 40 CS, 31 (78%) were prelabour deliveries.  Compared to the 
wider birthing population, women with JIA had significantly higher rates of preeclampsia, 
postpartum haemorrhage and severe maternal morbidity; and their pregnancies were significantly 
more likely to be delivered by CS or instrumentally even after adjusting for potential 
confounders including socio-economic status (see footnotes of Table 2).  Length of stay for the 
birth admission was longer in women with JIA than in the wider birthing population (mean: 7.1 
vs 4.0 days and median: 5 vs 4 days for women with JIA and the general population respectively; 
P<0.001 for median).  However, no differences between the two groups were observed in the 
other maternal outcomes: induction of labour, use of epidural, antepartum haemorrhage, 
episiotomy and 3rd-4th degree tear.  
 
Compared to infants from the wider birthing population, infants from women with JIA were 
more likely to be born preterm and to be admitted to a NICU and had a higher rate of severe 
neonatal morbidity (Table 3).  After adjusting for the predictors maternal age at birth, nulliparity, 
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hypertension, diabetes, socio-economic status and smoking during pregnancy, preterm birth 
remained statistically significantly different between the two groups.  The differences in rates of 
severe neonatal morbidity and admission to a NICU disappeared after adjusting for these 
predictors and preterm birth.  There was no difference in rates of infants small for gestational age 
or Apgar score < 7 at 5 minutes between the two groups.   
 
DISCUSSION 
To our knowledge, this is the first study that specifically investigates relationships between 
juvenile idiopathic arthritis and pregnancy outcomes.  The results indicate that women with a 
history of JIA are at increased risk of preterm delivery, obstetric interventions (CS or 
instrumental delivery) and the maternal complications preeclampsia, postpartum haemorrhage 
and severe maternal morbidity.  Also, compared to the wider birthing population, women with 
JIA had a longer birth admission and were less likely to become pregnant again.  However, the 
rate of abortion or miscarriage and the inter-pregnancy interval were similar among all women 
with a history of birth regardless of their JIA status.  Importantly, after controlling for the impact 
of known determinants of neonatal outcomes, there were no differences between women with 
JIA and their healthy counterparts in neonatal outcomes except that the rate of preterm birth was 
higher in women with JIA.  
 
For maternal outcomes, other studies of women with rheumatoid arthritis also reported an 
elevated risk of preeclampsia [14,15].  In contrast, in their study of first births, Wallenius et al 
[16] found that, compared to the general population, 128 women with chronic inflammatory 
arthritis (including JIA) were not at increased risk of preeclampsia, instrumental delivery or 
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postpartum haemorrhage but were at risk of vaginal bleeding during pregnancy, CS and 
induction of labour.  The reason for the increased risk of preeclampsia in our study is unclear and 
may be related to use of corticosteroids during the pregnancy [17].  Unfortunately, our datasets 
did not include information on use of drugs so we could not explore this possibility.  The 
increased risk of postpartum haemorrhage in our study was not related to the high CS rate in 
cases as the size of the risk did not change with additional adjustment for CS in the regression 
model (data not shown).  One explanation could be use of non-steroidal anti-inflammatory drugs 
(NSAIDs) during the pregnancy among the JIA patients.  Women might use NSAIDs while they 
were pregnant despite labels that warn against doing so.  In a USA case-control study published 
in 2001, 25% of the meconium samples in the control group were positive for NSAIDs [18].  
NSAIDs inhibit prostaglandin synthesis and may lead to increased blood loss during the 
postpartum period as prostaglandins are potent vasodilators and increase the permeability of 
blood vessels [19].  NSAIDs also have an anti-platelet effect and can increase bleeding through 
that mechanism [20].  
 
In women with a history of JIA, the high probability of an obstetric intervention during 
pregnancy is notable.  In our study, two thirds of JIA pregnancies involved either CS (51%) or 
instrumental delivery (17%).  Over 20 years ago, the high CS rate among women with JIA was 
already reported by Ostensen et al [4] and in that study, 24 of 76 (32%) JIA pregnancies were 
delivered by CS and, of these 24, 15 (63%) were due to sequelae of JIA.  Several studies on 
women with rheumatoid arthritis also reported increased risk of CS [14,15,21].  However, the 
finding of increased risk of instrumental delivery in women with JIA in our study has not been 
reported previously.  The observed increased risk of obstetric interventions in women with JIA 
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could be a result of their physical impairments.  Physical impairments such as chronic or 
recurrent pain or discomfort, incomplete use of feet or legs etc, are more pronounced in women 
with JIA than in women with adult-onset arthritis [1].  The high rate of maternal morbidity is 
also of concern.  Intensive obstetric care should therefore be provided during antenatal, birth and 
postpartum periods for women with JIA.  
 
For women with JIA who are planning to have children, the results of neonatal outcomes in our 
study might provide some comfort; but they should be aware the study is based on a small 
number of women with JIA.  Although only a small number of women with JIA were included in 
the study, they were likely to be severe cases as they were identified from hospital records.  
Hospital data only record diseases or conditions that require hospitalisation or that affect a 
hospital admission.  Other studies also found that risks of birth defect and transfer to NICU were 
not increased in women with chronic inflammatory arthritis [16,21,22].  However, increased risk 
of any or spontaneous preterm birth was found in our study and in other studies of women with 
chronic inflammatory arthritis [16,21,22].  Iatrogenic preterm birth might be a result of a timely 
delivery, albeit prematurely, to avoid stillbirth or complications.  In the 1980s and 1990s, women 
with autoimmune rheumatic diseases were often advised to avoid pregnancy [4].  It is now 
known that avoiding pregnancy when the diseases are active and continuing to take appropriate 
medication to keep autoimmune disease suppressed during pregnancy can reduce the risk of 
adverse pregnancy outcomes [17].  In a recent study, Viktil et al reported that the risk of 
congenital malformations was not increased in children born to mothers or fathers who had 
received anti-rheumatic drugs 3 months prior to pregnancy and/or during pregnancy [23].  Co-
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operation between obstetricians and physicians in caring for women with JIA could provide 
satisfactory pregnancy outcomes.  
 
With respect to women’s reproduction and fetal loss, contradictory findings to ours were 
reported in a case-control study by Ostensen et al in 2000 [5].  The authors found that Norwegian 
women with JIA (n=126) had a reduced fecundity and an increased risk of miscarriage but their 
fertility was not impaired.  In another study of 176 women with JIA who had mean disease 
duration of 28 years in United Kingdom in 2002, Packham et al reported women with psoriatic 
JIA had a significantly higher incidence of miscarriage (33%) than the other JIA groups (11%) 
[2].  In contrast, in two JIA case-control studies, Peterson et al [6] (44 cases) reported similar 
pregnancy rate and childbirth rate between two study groups in United States in 1997 and 
Wallenius et al [7] (75 cases) reported similar median inter-pregnancy interval among all study 
women in Norway in 2011.  Inconsistent results from these studies may be attributed to the small 
number of JIA cases in each study and/or differences in study methodology, study period and 
patient selection.  
 
A major limitation of our study is under ascertainment of JIA cases from hospital records.  Only 
50 women were identified from 601,659 women who gave birth over 10.5 years in NSW 
representing probably less than 10% of the JIA cases.  However, they would represent a much 
higher proportion of those women with active disease during the study period. Many children 
with arthritis will outgrow their illness and overall the prognosis of JIA is favourable, although 
this is dependent on the disease type [24].  For example, about 50% of systemic onset JIA cases 
remit without recurrence in adult.  Our study patients would presumably be among those with the 
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most active disease and so might be expected to have the worst pregnancy outcomes.  Using all 
other women who gave birth during the study period as the reference group in our study, a 
negative result for women with JIA could be reassuring.  Other limitations of our study include 
not knowing the type of JIA, the nature or degree of the women’s joint involvement and physical 
impairments, disease recurrence or use of medications.  It is possible that we have 
underestimated pregnancy losses, with only those resulting in hospital presentation included in 
our data.  Similar rates of pregnancy loss across the study population suggest ascertainment is 
not higher in women with JIA.  With only 6 cases of pregnancy loss in women with JIA it is hard 
to draw strong conclusions. 
 
In summary, women with a history of JIA in our study did not have an increased risk of having 
infants with adverse neonatal outcomes but premature birth could be a concern.  Also, CS or 
instrumental delivery was often required which could be due in part to their physical impairment 
so it is recommended that intensive obstetric care be provided during pregnancy.  Women with 
JIA might experience more maternal complications due to use of medications to suppress the 
disease activity or to the disease itself.  Co-operation between obstetricians and family 
physicians at the pregnancy planning stage and during the pregnancy should reduce these risks.  
 
ACKNOWLEDGEMENTS 
The authors thank the NSW Department of Health for access to the population health data and 
the NSW Centre for Health Record Linkage for linking the data sets.   
 
13 
 
Funding statement: This work was supported by an Australian National Health and Medical 
Research Council (NHMRC) Capacity Building Grant (#573122).   
 
Conflict of interest statement: The authors declare no conflicts of interest.  
14 
 
REFERENCES 
1 Australian Institute of Health and Welfare. Juvenile arthritis in Australia.  2008; Arthritis 
series no. 7. Cat. no. PHE 101. Canberra: AIHW. 
2 Packham JC , Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: 
social function, relationships and sexual activity. Rheumatology (Oxford) 2002; 41: 1440-
1443. 
3 Borchers AT, Selmi C, Cheema G et al. Juvenile idiopathic arthritis. Autoimmun Rev 2006; 
5: 279-98. 
4 Ostensen M. Pregnancy in patients with a history of juvenile rheumatoid arthritis. Arthritis 
Rheum 1991; 34: 881-87. 
5 Ostensen M, Almberg K, Koksvik HS. Sex, reproduction, and gynecological disease in 
young adults with a history of juvenile chronic arthritis. J Rheumatol 2000; 27: 1783-87. 
6 Peterson LS, Mason T, Nelson AM et al. Psychosocial outcomes and health status of adults 
who have had juvenile rheumatoid arthritis: a controlled, population-based study. Arthritis 
Rheum 1997; 40: 2235-40. 
7 Wallenius M, Skomsvoll JF, Irgens LM et al. Fertility in women with chronic inflammatory 
arthritides. Rheumatology (Oxford) 2011; 50: 1162-67. 
8 National Centre for Classification in Health. Australian Coding standards for ICD-10-AM 
and ACHI.  2004; 5th: 202. 
9 Lawrence G, Dinh I, Taylor L. The Centre for Health Record Linkage: a new resource for 
health services research and evaluation. HIM J 2008; 37: 60-62. 
15 
 
10  Australian Bureau of Statistics. Information Paper: An Introduction to Socio-Economic 
Indexes for Areas (SEIFA).  2006. Accessed date: 18/05/2012.  
http://www.abs.gov.au/ausstats/abs@.nsf/mf/2039.0 
11 Roberts CL , Lancaster PA. Australian national birthweight percentiles by gestational age. 
Med J Aust 1999; 170: 114-18. 
12 Lain SJ, Algert CS, Nassar N et al. Incidence of severe adverse neonatal outcomes: use of a 
composite indicator in a population cohort. Matern Child Health J 2012; 16: 600-608. 
13 Roberts CL, Cameron CA, Bell JC et al. Measuring maternal morbidity in routinely collected 
health data: development and validation of a maternal morbidity outcome indicator. Med 
Care 2008; 46: 786-94. 
14 Lin HC, Chen SF, Lin HC et al. Increased risk of adverse pregnancy outcomes in women 
with rheumatoid arthritis: a nationwide population-based study. Ann Rheum Dis 2010; 69: 
715-17. 
15 Skomsvoll JF, Ostensen M, Irgens LM et al. Pregnancy complications and delivery practice 
in women with connective tissue disease and inflammatory rheumatic disease in Norway. 
Acta Obstet Gynecol Scand 2000; 79: 490-495. 
16 Wallenius M, Skomsvoll JF, Irgens LM et al. Pregnancy and delivery in women with chronic 
inflammatory arthritides with a specific focus on first birth. Arthritis Rheum 2011; 63: 1534-
42. 
17 Gordon C. Pregnancy and autoimmune diseases. Best Pract Res Clin Rheumatol 2004; 18: 
359-79. 
16 
 
18. Alano MA, Ngougmna E, Ostrea EM et al. Analysis of nonsteroidal antiinflammatory drugs 
in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics 
2001; 107: 519-23. 
19 Fiddler MA. Rheumatoid arthritis and pregnancy: issues for consideration in clinical 
management. Arthritis Care Res 1997; 10: 264-72. 
20 Gladding PA, Webster MW, Farrell HB et al. The antiplatelet effect of six non-steroidal anti-
inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy 
volunteers. Am J Cardiol 2008; 101: 1060-1063. 
21 Reed SD, Vollan TA, Svec MA. Pregnancy outcomes in women with rheumatoid arthritis in 
Washington State. Matern Child Health J 2006; 10: 361-66. 
22 Norgaard M, Larsson H, Pedersen L et al. Rheumatoid arthritis and birth outcomes: a Danish 
and Swedish nationwide prevalence study. J Intern Med 2010; 268: 329-37. 
23 Viktil KK, Engeland A, Furu K. Outcomes after anti-rheumatic drug use before and during 
pregnancy: a cohort study among 150,000 pregnant women and expectant fathers. Scand J 
Rheumatol 2012; 41: 196-201. 
24 Minden K, Kiessling U, Listing J et al. Prognosis of patients with juvenile chronic arthritis 
and juvenile spondyloarthropathy. J Rheumatol 2000; 27: 2256-63. 
 
17 
 
Table 1 Characteristics at birth for women who gave birth in NSW during July 1, 2000 to 
December 31, 2010  
 
Characteristics at birth 
Women with Juvenile 
idiopathic arthritis 
General women   
N=78 births to 50 
women 
N=941,496 births 
to 601,659 women 
P* 
value 
Maternal age at any birth (year),^ 
median (range) 
29.5 (16.4 to 42.3) 30.6 (12.1 to 56.2) 0.09 
Nullipara at any birth,^ n (%) 44 (56) 394,569 (42) 0.01 
Plurality at any birth,^ n (%) 2 (2.6) 14,784 (1.6) 0.48 
Hypertension at any birth,^ n (%) 12 (15) 86,693 (9.2) 0.06 
Diabetes at any birth,^ n (%) 6 (7.7) 56,435 (6.0) 0.53 
Smoking during pregnancy at any 
birth,^  n (%) 
10 (13) 132,148 (14) 0.76 
Socio-economic status # at any 
birth,^ n (%) 
  
0.82 
    Most disadvantaged 14 (18) 204,720 (22) 
     Disadvantaged 14 (18) 177,659 (19) 
     Average 18 (23) 187,026 (20) 
     Advantaged 12 (15) 180,076 (19) 
     Most advantaged 20 (26) 182,215 (20) 
 Maternal age at first birth (year), 
median (range) 
28.1 (16.4 to 40.3) 28.9 (12.1 to 56.2) 0.07 
Abortion/miscarriage during the 
study period, n (%) 6 (12) 94,107 (16) 0.48 
Nullipara at last birth, n (%) 26 (52) 194,345 (32) 0.003 
Number of births at last birth, mean 
(SD) 
1.8 (1.0) 2.2 (1.2) 0.02 
Interval between 1st and 2nd 
pregnancies (years), median (range) 2.1 (1.5 to 3.5) 2.3 (0.8 to 10.5) 0.67 
^ Based on all 941,496 births during July 1, 2000 to December 31, 2010 
* Chi-square test, ANOVA test or Wilcoxon rank-sum test where appropriate 
# Using Index of Relative Socio-economic Disadvantage for Areas
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Table 2    Odds ratios (ORs)* of maternal outcomes for women with juvenile idiopathic arthritis 
 
 
Outcome variable 
 
Risk factor 
 
% 
Unadjusted OR 
[95%CI] 
Adjusted! OR 
[95%CI] 
Caesarean section     
    Juvenile RA  Yes  51.3 2.59 [1.54, 4.38] 2.78 [1.65, 4.68] 
 No 27.7 1.00 1.00 
Elective caesarean section    
    Juvenile RA  Yes  39.7 3.58 [2.11, 6.08] 4.64 [2.64, 8.15] 
 No 15.8 1.00 1.00 
Induction of labour     
    Juvenile RA  Yes  21.8 0.84 [0.48, 1.49] 0.73 [0.39, 1.36] 
 No 25.2 1.00 1.00 
Epidural     
    Juvenile RA  Yes  34.6 1.39[0.81, 2.38] 1.24 [0.68, 2.27] 
 No 25.4 1.00 1.00 
Episiotomy^     
    Juvenile RA Yes  13.2 0.78 [0.31, 1.98] 0.69 [0.26, 1.82] 
 No 15.9 1.00 1.00 
Instrumental delivery^     
    Juvenile RA Yes  34.2 2.99 [1.52, 5.90] 3.00 [1.34, 6.71] 
 No 14.7 1.00 1.00 
3rd-4th degree tear^     
    Juvenile RA Yes  0 N/A N/A 
 No 2.5 1.00 1.00 
Preeclampsia     
    Juvenile RA  Yes  7.7 3.10 [1.36, 7.03] 2.80 [1.23, 6.38] 
 No 2.6 1.00 1.00 
Antepartum haemorrhage     
    Juvenile RA Yes  1.3 0.97 [0.13, 7.08] 0.95 [0.13, 7.00] 
 No 1.4 1.00 1.00 
Postpartum haemorrhage    
    Juvenile RA Yes  18.0 2.45 [1.27, 4.72] 2.35 [1.23, 4.50] 
 No 8.3 1.00 1.00 
Severe maternal morbidity    
    Juvenile RA Yes  7.7 5.52 [1.81, 16.9] 5.11 [1.70, 15.3] 
 No 1.4 1.00 1.00 
* Lack of independence in study outcomes for multiple pregnancies in the same woman was 
taken into account using generalised estimating equations (GEE). 
! Adjusted for maternal age (i.e. <20, 20-34 and ≥35 years), parity, hypertension (except 
preeclampsia model), diabetes, socio-economic status and smoking during pregnancy.  
^ Excludes CS births. 
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Table 3    Odds ratios (ORs)* of neonatal outcomes for women with juvenile idiopathic arthritis  
 
 
Outcome variable 
 
Risk factor 
 
% 
Unadjusted OR 
[95%CI] 
Adjusted! OR 
[95%CI] 
Preterm birth (<37 weeks)    
    Juvenile RA  Yes  25.6 4.99 [2.71, 9.20] 4.72 [2.49, 8.97] 
 No 6.6 1.00 1.00 
Spontaneous preterm birth (<37 weeks)^    
    Juvenile RA  Yes  13.4 2.99 [1.23, 7.28] 2.89 [1.16, 7.24] 
 No 5.0 1.00 1.00 
Small for gestational age (<10th percentiles)    
    Juvenile RA  Yes  10.3 1.18 [0.56, 2.47] 1.05 [0.50, 2.21] 
 No 9.5 1.00 1.00 
Severe neonatal morbidity     
    Juvenile RA  Yes  11.5 3.03 [1.55, 5.95] 1.12 [0.50, 2.49] 
 No 4.2 1.00 1.00 
Apgar score at 5 minutes (<7)    
    Juvenile RA  Yes  2.6 1.88 [0.47, 7.52] 1.04 [0.28, 3.85] 
 No 1.4 1.00 1.00 
Admission to neonatal intensive care unit (>4 hrs)    
    Juvenile RA  Yes  33.3 2.74 [1.56, 4.83] 1.56 [0.87, 2.81] 
 No 15.4 1.00 1.00 
* Lack of independence in study outcomes for multiple pregnancies in the same woman was 
taken into account using generalised estimating equations (GEE). 
! Adjusted for maternal age (i.e. <20, 20-34 and ≥35 years), parity, hypertension, diabetes, socio-
economic status and smoking during pregnancy. Additional adjustment for preterm birth was 
applied to severe neonatal morbidity, Apgar score at 5 minutes and admission to neonatal 
intensive care unit.  
^ Excludes planned births, i.e. occurred before labour. 
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Figure 1 Frequency distribution of pregnancies by status of juvenile idiopathic arthritis 
  
